Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo (Q40787125)

23 September 2017

Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo (English)

1 reference

Middle East respiratory syndrome coronavirus

23 September 2017

0 references

author

Jens H. Kuhn

21

1 reference

23 September 2017

Christopher M Coleman

Christopher M Coleman

5

0 references

Eddie J. Sullivan

Eddie Sullivan

25

0 references

Stanley Perlman

Stanley Perlman

24

0 references

Gene G Olinger

Gene G Olinger

20

0 references

Lisa Hensley

19

Lisa E Hensley

1 reference

23 September 2017

18

Gale Smith

1 reference

23 September 2017

Thomas Luke

1

1 reference

23 September 2017

Hua Wu

2

1 reference

23 September 2017

Jincun Zhao

3

1 reference

23 September 2017

Rudragouda Channappanavar

4

1 reference

23 September 2017

Jin-An Jiao

6

1 reference

23 September 2017

Hiroaki Matsushita

7

1 reference

23 September 2017

Ye Liu

8

1 reference

23 September 2017

Elena N Postnikova

9

1 reference

23 September 2017

Britini L Ork

10

1 reference

23 September 2017

Gregory Glenn

11

1 reference

23 September 2017

David Flyer

12

1 reference

23 September 2017

Gabriel Defang

13

1 reference

23 September 2017

Kanakatte Raviprakash

14

1 reference

23 September 2017

Tadeusz Kochel

15

1 reference

23 September 2017

Jonathan Wang

16

1 reference

23 September 2017

Wensheng Nie

17

1 reference

23 September 2017

Michael R Holbrook

22

1 reference

23 September 2017

Reed F Johnson

23

1 reference

23 September 2017

Matthew B Frieman

26

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 February 2016

1 reference

Science Translational Medicine

23 September 2017

1 reference

23 September 2017

8

1 reference

23 September 2017

326

1 reference

23 September 2017

326ra21

1 reference

Hospital outbreak of Middle East respiratory syndrome coronavirus

23 September 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Transmission of MERS-coronavirus in household contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Middle East respiratory syndrome coronavirus in bats, Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Evidence for camel-to-human transmission of MERS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Crystal Structure of the Receptor-Binding Domain from Newly Emerged Middle East Respiratory Syndrome Coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Hark back: passive immunotherapy for influenza and other serious infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Triple immunoglobulin gene knockout transchromosomic cattle: bovine lambda cluster deletion and its effect on fully human polyclonal antibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Species-Specific Chromosome Engineering Greatly Improves Fully Human Polyclonal Antibody Production Profile in Cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Physiological level production of antigen-specific human immunoglobulin in cloned transchromosomic cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Antigen-specific human polyclonal antibodies from hyperimmunized cattle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Full-genome sequence of human betacoronavirus 2c jordan-n3/2012 after serial passage in Mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Rapid generation of a mouse model for Middle East respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Monoclonal antibodies for prophylactic and therapeutic use against viral infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

HBsAg variants: diagnostic-escape and diagnostic dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Infection with MERS-CoV causes lethal pneumonia in the common marmoset

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

IgG subclasses and allotypes: from structure to effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Growth and Quantification of MERS-CoV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

Real time quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.AAF1061

10.1126/SCITRANSLMED.AAF1061

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference